It has been also demonstrated that priming of protumor neutrophils with IFN-γ and TNF-α converts neutrophil function from tumor-promoting to tumor-suppressing state, through NK cells activation, thus suggesting that the administration of normal NK cells could represent a potential therapeutic approach in tumor therapy (145). This evidence concerns the gene IFNG and neoplasm.